InMed Pharmaceuticals Inc (INM)
0.3098
+0.03
(+10.84%)
USD |
NASDAQ |
Apr 24, 16:00
0.267
-0.04
(-13.82%)
After-Hours: 20:00
InMed Pharmaceuticals Free Cash Flow: -6.508M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.508M |
| September 30, 2023 | -7.364M |
| June 30, 2023 | -7.445M |
| March 31, 2023 | -10.80M |
| December 31, 2022 | -14.37M |
| September 30, 2022 | -15.22M |
| June 30, 2022 | -15.62M |
| March 31, 2022 | -13.58M |
| December 31, 2021 | -12.84M |
| September 30, 2021 | -11.07M |
| June 30, 2021 | -9.791M |
| March 31, 2021 | -9.182M |
| December 31, 2020 | -6.100M |
| September 30, 2020 | -6.391M |
| June 30, 2020 | -7.417M |
| March 31, 2020 | -7.948M |
| December 31, 2019 | -8.561M |
| September 30, 2019 | -7.769M |
| June 30, 2019 | -6.706M |
| March 31, 2019 | -5.770M |
| December 31, 2018 | -4.316M |
| September 30, 2018 | -3.838M |
| June 30, 2018 | -3.595M |
| March 31, 2018 | -3.435M |
| December 31, 2017 | -3.494M |
| Date | Value |
|---|---|
| September 30, 2017 | -3.312M |
| June 30, 2017 | -2.385M |
| March 31, 2017 | -1.621M |
| December 31, 2016 | -0.9594M |
| September 30, 2016 | -0.4237M |
| June 30, 2016 | -0.387M |
| March 31, 2016 | -1.078M |
| December 31, 2015 | -1.650M |
| September 30, 2015 | -1.638M |
| June 30, 2015 | -1.612M |
| March 31, 2015 | -1.491M |
| December 31, 2014 | -0.8326M |
| September 30, 2014 | -0.7412M |
| June 30, 2014 | -0.6414M |
| March 31, 2014 | 0.0008M |
| December 31, 2013 | 0.0011M |
| September 30, 2013 | -0.0142M |
| June 30, 2013 | -0.0393M |
| March 31, 2013 | -0.0828M |
| December 31, 2012 | -0.102M |
| September 30, 2012 | -0.1624M |
| June 30, 2012 | -0.1746M |
| March 31, 2012 | -0.5013M |
| December 31, 2011 | -0.664M |
| September 30, 2011 | -0.5983M |
Free Cash Flow Range, Past 5 Years
-15.62M
Minimum
Jun 2022
-6.100M
Maximum
Dec 2020
-9.721M
Average
-8.561M
Median
Dec 2019
Free Cash Flow Benchmarks
| Rimrock Gold Corp | -- |
| Venus Concept Inc | -- |
| Juva Life Inc | -10.64M |
| CEN Biotech Inc | -0.2248M |
| Lucy Scientific Discovery Inc | -6.046M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.848M |
| Cash from Investing (Quarterly) | -0.0093M |
| Cash from Financing (Quarterly) | 4.654M |
| Free Cash Flow Per Share (Quarterly) | -0.233 |
| Free Cash Flow to Equity (Quarterly) | -1.857M |
| Free Cash Flow to Firm (Quarterly) | -1.857M |
| Free Cash Flow Yield | -468.0% |